Advanced

Prostate cancer and active surveillance.

Abrahamsson, Per-Anders LU (2008) In Frontiers of Radiation Therapy and Oncology 41. p.41280-41280
Abstract
This review outlines the different treatment options in localized prostate cancer. This information can be considered alongside other important factors, such as the individual patient's values and situation as well as the potential impact of treatment on his quality of life, in the treatment decision-making process. Taking all these factors into consideration, the data support active surveillance as an appropriate choice in patients with well or moderately differentiated, low-volume prostate cancer who have a life expectancy of less than 10 years. Men with higher-grade tumors and longer life expectancy may be at excess risk of death from prostate cancer managed with active surveillance.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Frontiers of Radiation Therapy and Oncology
volume
41
pages
41280 - 41280
publisher
S. Karger AG
external identifiers
  • WOS:000258328000001
  • PMID:18544979
  • Scopus:49449093298
ISSN
0071-9676
DOI
10.1159/000139867
language
English
LU publication?
yes
id
bc0691fd-5b64-4d8a-9bc4-2ddd4142e6fe (old id 1168916)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/18544979?dopt=Abstract
date added to LUP
2008-07-04 09:47:24
date last changed
2016-10-13 04:26:27
@misc{bc0691fd-5b64-4d8a-9bc4-2ddd4142e6fe,
  abstract     = {This review outlines the different treatment options in localized prostate cancer. This information can be considered alongside other important factors, such as the individual patient's values and situation as well as the potential impact of treatment on his quality of life, in the treatment decision-making process. Taking all these factors into consideration, the data support active surveillance as an appropriate choice in patients with well or moderately differentiated, low-volume prostate cancer who have a life expectancy of less than 10 years. Men with higher-grade tumors and longer life expectancy may be at excess risk of death from prostate cancer managed with active surveillance.},
  author       = {Abrahamsson, Per-Anders},
  issn         = {0071-9676},
  language     = {eng},
  pages        = {41280--41280},
  publisher    = {ARRAY(0x52db128)},
  series       = {Frontiers of Radiation Therapy and Oncology},
  title        = {Prostate cancer and active surveillance.},
  url          = {http://dx.doi.org/10.1159/000139867},
  volume       = {41},
  year         = {2008},
}